Insider · CIK 0000941841
Lindsay A Rosenwald Md
Files at FBIO (Fortress Biotech, Inc.), CKPT (Checkpoint Therapeutics, Inc.), DERM (Journey Medical Corp). First filing -, latest -.
Lindsay A Rosenwald Md files SEC Form 4 as director, CEO, president, chair and 10% owner at FBIO (Fortress Biotech, Inc.), and also at CKPT (Checkpoint Therapeutics, Inc.), DERM (Journey Medical Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lindsay A Rosenwald Md has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | FBIO Fortress Biotech, Inc. | AGrant or award Common stock, par value $0.001 | +475,424 | $0.00 | $0 | 4,586,841 | Mar 20, 2026 |
| Aug 5, 2025 | DERM Journey Medical Corp | AGrant or award Common Stock, $0.0001 par value | +50,000 | $0.00 | $0 | 211,146 | Aug 7, 2025 |
| Jun 25, 2025 | DERM Journey Medical Corp | AGrant or award Common Stock, $0.0001 par value | +7,173 | $0.00 | $0 | 161,146 | Jul 7, 2025 |
| May 28, 2025 | CKPT Checkpoint Therapeutics, Inc. | AGrant or award COMMON STOCK | +12,195 | $0.00 | $0 | 157,007 | May 30, 2025 |
| May 29, 2025 | CKPT Checkpoint Therapeutics, Inc. | AGrant or award COMMON STOCK | +50,000 | $1.29 | $65k | 207,007 | May 30, 2025 |
| May 30, 2025 | CKPT Checkpoint Therapeutics, Inc. | UTender of shares COMMON STOCK | -207,007 | - | - | 0 | May 30, 2025 |
| Jan 1, 2025 | FBIO Fortress Biotech, Inc. | AGrant or award Common stock, par value $0.001 | +454,153 | $0.00 | $0 | 4,111,417 | Jan 3, 2025 |
| Dec 13, 2024 | CKPT Checkpoint Therapeutics, Inc. | AGrant or award COMMON STOCK | +12,638 | $0.00 | $0 | 144,812 | Dec 17, 2024 |
Questions about Lindsay A Rosenwald Md
Answered from the filings on this page, as of the latest one.
Is Lindsay A Rosenwald Md buying or selling?
Lindsay A Rosenwald Md has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lindsay A Rosenwald Md's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lindsay A Rosenwald Md has 0.
Where does Lindsay A Rosenwald Md file Form 4?
Lindsay A Rosenwald Md has filed Form 4 at FBIO (Fortress Biotech, Inc.) as PRESIDENT, CEO & CHAIRMAN; CKPT (Checkpoint Therapeutics, Inc.); DERM (Journey Medical Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.